PGL2001 Proof of Concept Study in Symptomatic Endometriosis

Summary

This is a Phase II, multicentre, randomised, two-arm, parallel group ,double-blind, placebo controlled, study to investigate the efficacy, safety, pharmacokinetics and pharmacodynamics of the steroid sulfatase inhibitor PGL2001 with concomitant, continuous NETA administration for the treatment of pain symptoms suggestive of endometriosis. The target population will be women of reproductive age with symptoms suggestive of endometriosis.

Timeline

Start

2012-06

Primary completion

2013-10

Completion

2014-05

Drugs

Indications